Technology - CytoVeris Inc.

Target Tissue Identification through the detection
of Intrinsic Biomolecular Markers using
Multispectral Autofluorescence Imaging

Target Tissue Identification through the detection of Intrinsic Biomolecular Markers using
Multispectral Autofluorescence Imaging.

STEP 1

Multi-Spectral Illumination

STEP 2

Multi-Spectral Detection

STEP 3

Train AI/ML Algorithms

CytoVeris’ UV-Excited Tissue Autofluoresence Imaging allows the differentiation of tissue types & structures

Validated our Technology Platform

Trained on Ground Truth Data using LOPO

Tested using 5-Fold Cross Validation Data Sets

Patient = 92
Specimen Blocks = 139
Targets = 473

SENSITIVITY = 90.6%
SPECIFICITY = 89.9%
ACCURACY = 90.1%

Real-time imaging during prostatectomy could improve the odds of preservation of function and reduce recurrence for 90,000 men in the U.S. per year.

60% reduction in the breast cancer positive margin rate nationwide could avoid reoperations for 30,000 women annually.

Real-time bladder resection imaging could avoid 70,000 repeat TURBT procedures per year in the U.S.